Design, Synthesis, and in Vitro and in Vivo Biological Evaluation of Limonin Derivatives for Anti-Inflammation Therapy.

Ming Bian,Guohua Gong,Pang Lei,Huanhuan Du,Chunmei Bai,Chengxi Wei,Zheshan Quan,Qianqian Ma
DOI: https://doi.org/10.1021/acs.jafc.1c04989
IF: 6.1
2021-01-01
Journal of Agricultural and Food Chemistry
Abstract:In this study, limonin derivatives were used to design new anti-inflammatory compounds with high pharmacological activity and low toxicity. A total of 23 new limonin derivatives were discovered, synthesized, and screened for their anti-inflammatory activity against lipopolysaccharide (LPS)-treated RAW 264.7 cells. Of them, compound f4 was found to be the most active, with a higher efficiency compared with limonin and celecoxib. Subsequently, we studied the mechanism underlying the activity of f4 and found that it inhibited proinflammatory cytokines by blocking the NF-κB/MAPK signaling pathway in LPS-treated RAW 264.7 cells as well as mice. In conclusion, f4 may be a promising anti-inflammatory lead compound.
What problem does this paper attempt to address?